Short Protocol Barostat for Assessment of Anorectal Function Versus Standard Protocol Barostat in Healthy Volunteers

November 13, 2012 updated by: University of Zurich

The aim of this monocentric, prospective, non randomised study with 25 healthy volunteers is to assess anorectal function ( i.e rectal compliance and sensory thresholds) in health with a short protocol barostat versus conventional procedures (i.e. standard barostat protocol and high resolution anorectal manometry). Anorectal dysfunction is a key mechanism in the development of fecal incontinence and symptoms of obstructive defecation.

In this study volunteers will be examined - after explanation, physical examination and verification of in- and exclusion criteria - by anorectal barostat with short and standard protocol as well as by proctoscopy and endoanal ultrasound.

Study Overview

Status

Completed

Conditions

Detailed Description

For a coordinated anorectal function in addition to the anal sphincter the perception of rectal distension (visceral perception) and elasticity / compliance of the anorectum and stool consistency is important. A disturbed anorectal function may lead to functional defecation disorders or incontinence.

The currently available methods for measuring physiological assessment of anorectal function mostly focus on measurement of sphincter pressures, but generally provide no complete explanation for the underlying pathophysiology of defecation disorders. By voluntary contraction of the striated muscles of the external anal sphincter and puborectalis muscle defecation can be further delayed. In addition, however, other continence mechanisms play an important role.

The Group for the Study of functional gastrointestinal disorders at the Clinic for Gastroenterology at the University Hospital of Zurich has a great expertise in the establishment of new research methods such as the already in routine clinical practice used high-resolution anorectal manometry and has conducted numerous studies with anorectal Barostat. To use the results of Barostat also in everyday clinical practice in patients with defecation disorders this technique means significant simplification of the instrumental methodology and shortening of the work described in the literature. Before the simplified barostat can be used with the shortened protocol in different patient groups and clinical practice, it generally requires the validation of the technique in healthy subjects to define the range of normal values.

Study Type

Interventional

Enrollment (Actual)

26

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Zurich, Switzerland, 8091
        • University Hospital Zurich, Gastroenterology and Hepatology

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 61 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria:

  • Healthy men and women between 18 and 65 years of age without gastrointestinal disease needing medical or surgical treatment.
  • No medication (with the exception of occasional intake of paracetamol)
  • Availability of all investigations (high resolution anorectal manometry, anorectal barostat with short and standard protocol, proctoscopy and endoanal ultrasound to assess sphincter morphology)
  • Good communication with study doctor and meeting of all study requirements.
  • Written consent after detailed explanation of study.

Exclusion criteria:

  • Gastrointestinal symptoms especially fecal incontinence and obstructed defecation
  • Structural or functional changes of upper and lower GI Tract (i.e gastric ulcer, malignancy , symptoms of IBS)
  • Symptomatic or manometrically diagnosed motility disorders of the upper and lower GI tract for example anismus
  • Surgery or interventions in the lower and upper GI tract (appendectomy and hernia excluded) included congenital malformations
  • Pelvic radiation therapy
  • Fecal incontinence, defined as involuntary loss of liquid or hard stool
  • Functional defecation disorders as defined by the ROME III criteria.
  • Pregnancy with history of vaginal delivery.
  • Acute or chronic disease ( for example IBD)
  • Malignancy
  • Intake of medication one week prior to study begin. Anticoagulants and medication influencing GI motility like prokinetics, calcium channel blockers and antibiotics
  • Drug or alcohol use
  • Pregnancy and lactation
  • Women at reproductive age will receive pregnancy testing before inclusion into study.
  • Physical, mental , neurological or psychiatric conditions limiting ability to meet inclusion criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Assessment of anorectal perception thresholds with short protocol barostat in healthy volunteers
Time Frame: during hospital stay, estmated 0.5 days
during hospital stay, estmated 0.5 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
anorectal perception thresholds in % in relation to rectal capacity assessed in ml
Time Frame: at time of hospital stay approx 0.5 days

Comparison of anorectal perception thresholds and rectal capacity with the simplified barostat protocol with:

  1. the anorectal perception thresholds and rectal capacity in accordance with the standard protocol
  2. the pressure of the anal sphincter and the length at rest and during voluntary contraction,
  3. the length and the morphological integrity of the anal sphincter detected by ultrasound
at time of hospital stay approx 0.5 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Heiko Fruehauf, MD, University Hospital Zurich, Division of Gastroenterology and Hepatology

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2011

Primary Completion (Actual)

November 1, 2012

Study Completion (Actual)

November 1, 2012

Study Registration Dates

First Submitted

September 26, 2011

First Submitted That Met QC Criteria

October 18, 2011

First Posted (Estimate)

October 20, 2011

Study Record Updates

Last Update Posted (Estimate)

November 14, 2012

Last Update Submitted That Met QC Criteria

November 13, 2012

Last Verified

November 1, 2012

More Information

Terms related to this study

Other Study ID Numbers

  • KEK-ZH-Nr. 2010-0330

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on anorectal manometry

Subscribe